Preclinical and clinical efficacy of trastuzumab deruxtecan in breast cancer brain metastases (BCBM)

被引：4
|
作者：
Kabraji, Sheheryar
Ni, Jing
Sammons, Sarah
Van Swearingen, Amanda E. D.
Wang, Yanzhi
Pereslete, Alyssa M.
Hsu, Liangge
Lascola, Chris
Moore, Heather
Hughes, Melissa
Raghavendra, Akshara S.
Gule-Monroe, Maria
Murthy, Rashmi K.
Winer, Eric P.
Anders, Carey K.
Zhao, Jean J.
Lin, Nancy U.
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS21-PD4-05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD4-05
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Multi-Institutional Report of Trastuzumab-Deruxtecan and Stereotactic Radiosurgery for HER2+Breast Cancer Brain Metastases
    Khatri, V.
    Mestres-Villanueva, M.
    Doniparthi, A.
    Smith, D. B.
    Nakashima, J. Y.
    Zhao, D.
    Bryant, J. M.
    Mills, M. N.
    Oliver, D. E.
    Yu, H. H. M.
    Han, H. S.
    Soliman, H.
    Perlow, H. K.
    Upadhyay, R.
    Palmer, J. D.
    Beyer, S.
    Ahmedm, K. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E243 - E244
  • [32] Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial
    Rupert Bartsch
    Anna Sophie Berghoff
    Julia Furtner
    Maximilian Marhold
    Elisabeth Sophie Bergen
    Sophie Roider-Schur
    Angelika Martina Starzer
    Heidrun Forstner
    Beate Rottenmanner
    Karin Dieckmann
    Zsuzsanna Bago-Horvath
    Helmuth Haslacher
    Georg Widhalm
    Aysegül Ilhan-Mutlu
    Christoph Minichsdorfer
    Thorsten Fuereder
    Thomas Szekeres
    Leopold Oehler
    Birgit Gruenberger
    Christian F. Singer
    Ansgar Weltermann
    Rainer Puhr
    Matthias Preusser
    Nature Medicine, 2022, 28 : 1840 - 1847
  • [33] Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial
    Bartsch, Rupert
    Berghoff, Anna Sophie
    Furtner, Julia
    Marhold, Maximilian
    Bergen, Elisabeth Sophie
    Roider-Schur, Sophie
    Starzer, Angelika Martina
    Forstner, Heidrun
    Rottenmanner, Beate
    Dieckmann, Karin
    Bago-Horvath, Zsuzsanna
    Haslacher, Helmuth
    Widhalm, Georg
    Ilhan-Mutlu, Aysegul
    Minichsdorfer, Christoph
    Fuereder, Thorsten
    Szekeres, Thomas
    Oehler, Leopold
    Gruenberger, Birgit
    Singer, Christian F.
    Weltermann, Ansgar
    Puhr, Rainer
    Preusser, Matthias
    NATURE MEDICINE, 2022, 28 (09) : 1840 - +
  • [34] Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A DESTINY-Breast01 Subgroup Analysis
    Jerusalem, Guy
    Park, Yeon Hee
    Yamashita, Toshinari
    Hurvitz, Sara A.
    Modi, Shanu
    Andre, Fabrice
    Krop, Ian E.
    Farre, Xavier Gonzalez
    You, Benoit
    Saura, Cristina
    Kim, Sung-Bae
    Osborne, Cynthia R.
    Murthy, Rashmi K.
    Gianni, Lorenzo
    Takano, Toshimi
    Liu, Yali
    Cathcart, Jillian
    Lee, Caleb
    Perrin, Christophe
    CANCER DISCOVERY, 2022, 12 (12) : 2754 - 2762
  • [35] Safety and Efficacy of Combined Trastuzumab-Deruxtecan and Concurrent Radiation Therapyin Breast Cancer: The TENDANCE Multicentric French Study (Trastuzumab-Deruxtecan and Concurrent Radiation Therapy in Breast Cancer)
    Debbi, K.
    Benderra, M. A.
    Medioni, J.
    Durdux, C.
    Asmahane, B.
    Monnier, L.
    Gligorov, J.
    Assaf, E.
    Belkacemi, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S103 - S103
  • [36] Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer patients with brain metastases from the randomized DESTINY-Breast03 trial
    Hurvitz, S. A.
    Kim, S. -B.
    Chung, W. -P.
    Im, S. -A.
    Park, Y. H.
    Hegg, R.
    Kim, M. -H.
    Tseng, L. -M.
    Petry, V.
    Chung, C. -F.
    Iwata, H.
    Hamilton, E.
    Curigliano, G.
    Xu, B.
    Egorov, A.
    Liu, Y.
    Cathcart, J.
    Bako, E.
    Tecson, K.
    Verma, S.
    Cortes, J.
    ESMO OPEN, 2024, 9 (05)
  • [37] Intracranial breast cancer brain metastases (BCBM) models - stereotactic vs. intracarotid inoculation
    Cold, Sigrid
    Braig, Moritz
    Engel, Trine Bjoernbo
    Alfsen, Maria Zeiler
    Kristiansen, Maria Nikoline
    Kristensen, Lotte Kellemann
    Kjaer, Andreas
    Nielsen, Carsten Haagen
    CANCER RESEARCH, 2023, 83 (07)
  • [38] Efficacy and Safety of Trastuzumab Deruxtecan in Breast Cancer: A Systematic Review and Meta-Analysis
    Dowling, Gavin P.
    Daly, Gordon R.
    Keelan, Stephen
    Boland, Fiona
    Toomey, Sinead
    Hill, Arnold D. K.
    Hennessy, Bryan T.
    CLINICAL BREAST CANCER, 2023, 23 (08) : 847 - 855.e2
  • [39] Treatment with trastuzumab deruxtecan in patients with HER2-positive breast cancer and brain metastases and/or leptomeningeal disease (ROSET-BM)
    Naoki Niikura
    Takashi Yamanaka
    Hironori Nomura
    Kazuhiro Shiraishi
    Hiroki Kusama
    Mitsugu Yamamoto
    Kazuo Matsuura
    Kenichi Inoue
    Sachiko Takahara
    Shosuke Kita
    Miki Yamaguchi
    Tomoyuki Aruga
    Nobuhiro Shibata
    Akihiko Shimomura
    Yuri Ozaki
    Shuji Sakai
    Yoko Kiga
    Tadahiro Izutani
    Kazuhito Shiosakai
    Junji Tsurutani
    npj Breast Cancer, 9
  • [40] Treatment with trastuzumab deruxtecan in patients with HER2-positive breast cancer and brain metastases and/or leptomeningeal disease (ROSET-BM)
    Niikura, Naoki
    Yamanaka, Takashi
    Nomura, Hironori
    Shiraishi, Kazuhiro
    Kusama, Hiroki
    Yamamoto, Mitsugu
    Matsuura, Kazuo
    Inoue, Kenichi
    Takahara, Sachiko
    Kita, Shosuke
    Yamaguchi, Miki
    Aruga, Tomoyuki
    Shibata, Nobuhiro
    Shimomura, Akihiko
    Ozaki, Yuri
    Sakai, Shuji
    Kiga, Yoko
    Izutani, Tadahiro
    Shiosakai, Kazuhito
    Tsurutani, Junji
    NPJ BREAST CANCER, 2023, 9 (01)
12345